Clinical Trial ROBERT® - Project Active Training

Lifescience-Robotics8 enrolled

Overview

The overall purpose with this clinical trial is to, monitor and secure ROBERT®'s clinical performance and safety in a clinical environment in the regional hospital North Denmark, Neuro Unit North. The purpose of the study is to investigate if ROBERT® has the ability to 1. Perform guided active training. 2. Perform resistance based active training. And validate the safety of ROBERT® in a clinical environment.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

DEVICE_FEASIBILITY

Masking

NONE

Enrollment

Conditions

Apoplexy; Stroke Spinal Cord Injuries Safety Usability

Interventions

ROBERT®DEVICE

Robotic Rehabilitation intervention ROBERT®, designed for early, and supplementary therapy of patients.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Hospitalised patients at Neuro Unit North, during the trial period. * 18 years or older. * Can read, understand and speak Danish * Reduced motor function in lower extremities. Exclusion Criteria: * No able to sign informed consent. * Cannot read, understand or speak Danish * Patients with unstable fractures in columna, pelvis or lower extremities. * Patients with the risk of ulcers, or with exceedingly sensitive skin. * The patient is refusing to train with ROBERT®

Locations (1)

Region Hospital, Neuro Unit Nord.

Frederikshavn, North Denmark, Denmark

Outcomes

Primary Outcomes

Active training and assistive training capabilities (3 active and 3 passive motions): evaluated as passed/not passed

1. Active training capabilities will be assessed, 3 active motions are planned (the therapist has to be active) by the therapist, and manually performed by hand. The resistance perceived by the therapist is then compared to the expert opinion of the therapist to evaluate if this correlates with, small, medium, and large resistance. This is evaluated as passed/not passed for all 3 motions 2. Active assistive training capabilities will be assessed: 3 passive motions are planned (the robot moves, the therapist follows movement), by the therapist and the robot starts performing the motions, the therapist performs a small, moderate and large assistive movement in conjunction with the robot. The results in % of activity in the path of motion are displayed, and the therapist evaluates if this is in agreement with what they would categorise as a small, moderate and large assistive movement respectively. This is evaluated as passed/not passed for all 3 motions.

Time frame: Up to 19 weeks

Safety, Capture adverse events.

Safety is evaluated during patient use, nr of treatment-related adverse events is recorded during training sessions.

Time frame: Up to 19 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.